NSC |
Compound |
Enrichment |
Correlation |
NSC 724794 |
5-Benzyl-9-hydroxy-5H-indeno[1,2-b]indol-10-one |
0.0420893367628879 |
-0.060670013 |
NSC 724827 |
1,4-di-N-oxide-6,7-difluoro-2-ethylcarbonyl-3-trifluoromethy lquinoxaline |
0.0420893367628879 |
0.058706112 |
NSC 726863 |
6-[4-(1-cyclohexenyl)-1,3-butadiyn-1-yl]-2(2H)-pyranone |
0.0420893367628879 |
0.037045589 |
NSC 727985 |
NSC 708781 incorporated in micelles, 0.55% (w/w) of drug |
0.0420893367628879 |
0.51926671 |
NSC 728319 |
6-(3-Homopiperazinyl1-1-propyl)-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride |
0.0420893367628879 |
0.33174662 |
NSC 731155 |
6-(3-Aminopropyl)-5,6-dihydro-5,11-dioxo-3-nitro-11H-indeno[ 1,2-c]isoquinoline Hydrochloride salt |
0.0420893367628879 |
0.20549014 |
NSC 737318 |
6-(3-Chloropropyl)-5,6-dihydro-2,3,9-trimethoxy-5,11-dioxo-1 1H-indeno[1,2-c]isoquinoline |
0.0420893367628879 |
0.26628833 |
NSC 740386 |
3,7-di(trifluoromethyl)-2-furoylquioxaline 1,4-dioxide |
0.0420893367628879 |
0.35542247 |
NSC 254681 |
5(8H)-Naphthacenone, 8-acetyl-10-[(3-amino-2,3,6-trideoxy- .alpha.-L-lyxo-hexopyranosyl)oxy]-7,9,10,12-tetrahydro-6,8,~ 11-trihydroxy-12-imino-1-methoxy-, monohydrochloride, (8S-cis)- (9CI) |
0.0430277102950697 |
0.23690522 |
NSC 269599 |
Stannane, chlorohydroxydiphenyl- |
0.0430277102950697 |
0.045987267 |